Human Molecular Genetics Advance Access originally published online on January 20, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 6 609-616
DOI: 10.1093/hmg/ddh065
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions
1Stanford Human Genome Center and 2Department of Genetics, Stanford University School of Medicine, Stanford, California, USA, 3Department of Psychiatry and Human Behavior, University of California, Irvine, California, USA, 4Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan, USA and 5Center for Neuroscience, University of California, Davis, California, USA
Received October 17, 2003; Revised December 15, 2003; Accepted January 12, 2004
Studies of gene expression abnormalities in psychiatric or neurological disorders often involve the use of postmortem brain tissue. Compared with single-cell organisms or clonal cell lines, the biological environment and medical history of human subjects cannot be controlled, and are often difficult to document fully. The chance of finding significant and replicable changes depends on the nature and magnitude of the observed variations among the studied subjects. During an analysis of gene expression changes in mood disorders, we observed a remarkable degree of natural variation among 120 samples, which represented three brain regions in 40 subjects. Most of such diversity can be accounted for by two distinct expression patterns, which in turn are strongly correlated with tissue pH. Individuals who suffered prolonged agonal states, such as with respiratory arrest, multi-organ failure or coma, tended to have lower pH in the brain; whereas those who experienced brief deaths, associated with accidents, cardiac events or asphyxia, generally had normal pH. The lower pH samples exhibited a systematic decrease in expression of genes involved in energy metabolism and proteolytic activities, and a consistent increase of genes encoding stress-response proteins and transcription factors. This functional specificity of changed genes suggests that the difference is not merely due to random RNA degradation in low pH samples; rather it reflects a broad and actively coordinated biological response in living cells. These findings shed light on critical molecular mechanisms that are engaged during different forms of terminal stress, and may suggest clinical targets of protection or restoration.
* To whom correspondence should be addressed at: Department of Genetics, M344, Stanford University School of Medicine, Stanford, CA 94305, USA. E-mail: myers{at}shgc.stanford.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Verlaan, B. Ge, E. Grundberg, R. Hoberman, K. C.L. Lam, V. Koka, J. Dias, S. Gurd, N. W. Martin, H. Mallmin, et al. Targeted screening of cis-regulatory variation in human haplotypes Genome Res., January 1, 2009; 19(1): 118 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Eggan, T. Hashimoto, and D. A. Lewis Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia Arch Gen Psychiatry, July 1, 2008; 65(7): 772 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Liang, T. Dunckley, T. G. Beach, A. Grover, D. Mastroeni, D. G. Walker, R. J. Caselli, W. A. Kukull, D. McKeel, J. C. Morris, et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain Physiol Genomics, February 12, 2007; 28(3): 311 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Iwamoto and T. Kato Gene Expression Profiling in Schizophrenia and Related Mental Disorders Neuroscientist, August 1, 2006; 12(4): 349 - 361. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Jordan and U. Francke Ube3a expression is not altered in Mecp2 mutant mice Hum. Mol. Genet., July 15, 2006; 15(14): 2210 - 2215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Gruber, C. D. Coldren, M. D. Woolum, G. P. Cosgrove, C. Zeng, A. E. Baron, M. D. Moore, C. D. Cool, G. S. Worthen, K. K. Brown, et al. Human Lung Project: Evaluating Variance of Gene Expression in the Human Lung Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 65 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nakatani, E. Hattori, T. Ohnishi, B. Dean, Y. Iwayama, I. Matsumoto, T. Kato, N. Osumi, T. Higuchi, S.-I. Niwa, et al. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation Hum. Mol. Genet., June 15, 2006; 15(12): 1949 - 1962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Artal-Sanz, C. Samara, P. Syntichaki, and N. Tavernarakis Lysosomal biogenesis and function is critical for necrotic cell death in Caenorhabditis elegans J. Cell Biol., April 24, 2006; 173(2): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. H. Stead, C. Neal, F. Meng, Y. Wang, S. Evans, D. M. Vazquez, S. J. Watson, and H. Akil Transcriptional Profiling of the Developing Rat Brain Reveals That the Most Dramatic Regional Differentiation in Gene Expression Occurs Postpartum J. Neurosci., January 4, 2006; 26(1): 345 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sequeira, F. G. Gwadry, J. M. H. ffrench-Mullen, L. Canetti, Y. Gingras, R. A. Casero Jr, G. Rouleau, C. Benkelfat, and G. Turecki Implication of SSAT by Gene Expression and Genetic Variation in Suicide and Major Depression Arch Gen Psychiatry, January 1, 2006; 63(1): 35 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Lewandowski and S. A. Small Brain Microarray: Finding Needles in Molecular Haystacks J. Neurosci., November 9, 2005; 25(45): 10341 - 10346. [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. Choudary, M. Molnar, S. J. Evans, H. Tomita, J.Z. Li, M. P. Vawter, R. M. Myers, W. E. Bunney Jr., H. Akil, S. J. Watson, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression PNAS, October 25, 2005; 102(43): 15653 - 15658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li and M. Burmeister Genetical genomics: combining genetics with gene expression analysis Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R163 - R169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Iwamoto, M. Bundo, and T. Kato Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis Hum. Mol. Genet., January 15, 2005; 14(2): 241 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. de Yebra, R. Adroer, N. de Gregorio-Rocasolano, R. Blesa, R. Trullas, and N. Mahy Reduced KIAA0471 mRNA expression in Alzheimer's patients: a new candidate gene product linked to the disease? Hum. Mol. Genet., November 1, 2004; 13(21): 2607 - 2612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Evans, P. V. Choudary, C. R. Neal, J. Z. Li, M. P. Vawter, H. Tomita, J. F. Lopez, R. C. Thompson, F. Meng, J. D. Stead, et al. Dysregulation of the fibroblast growth factor system in major depression PNAS, October 26, 2004; 101(43): 15506 - 15511. [Abstract] [Full Text] [PDF]
|
|